Literature DB >> 33449153

Mechanisms of fungal dissemination.

Ashley B Strickland1, Meiqing Shi2.   

Abstract

Fungal infections are an increasing threat to global public health. There are more than six million fungal species worldwide, but less than 1% are known to infect humans. Most of these fungal infections are superficial, affecting the hair, skin and nails, but some species are capable of causing life-threatening diseases. The most common of these include Cryptococcus neoformans, Aspergillus fumigatus and Candida albicans. These fungi are typically innocuous and even constitute a part of the human microbiome, but if these pathogens disseminate throughout the body, they can cause fatal infections which account for more than one million deaths worldwide each year. Thus, systemic dissemination of fungi is a critical step in the development of these deadly infections. In this review, we discuss our current understanding of how fungi disseminate from the initial infection sites to the bloodstream, how immune cells eliminate fungi from circulation and how fungi leave the blood and enter distant organs, highlighting some recent advances and offering some perspectives on future directions.

Entities:  

Keywords:  Aspergillus fumigatus; Candida albicans; Cryptococcus neoformans; Fungal pathogenesis; Fungus; Invasive aspergillosis; Invasive candidiasis; Meningoencephalitis; Paracellular crossing; Transcytosis; Trojan horse

Mesh:

Substances:

Year:  2021        PMID: 33449153      PMCID: PMC8044058          DOI: 10.1007/s00018-020-03736-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  163 in total

Review 1.  Cryptococcal interactions with the host immune system.

Authors:  Kerstin Voelz; Robin C May
Journal:  Eukaryot Cell       Date:  2010-04-09

Review 2.  Antifungal Innate Immunity: A Perspective from the Last 10 Years.

Authors:  Fabián Salazar; Gordon D Brown
Journal:  J Innate Immun       Date:  2018-05-16       Impact factor: 7.349

3.  Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.

Authors:  Radha Rajasingham; Rachel M Smith; Benjamin J Park; Joseph N Jarvis; Nelesh P Govender; Tom M Chiller; David W Denning; Angela Loyse; David R Boulware
Journal:  Lancet Infect Dis       Date:  2017-05-05       Impact factor: 25.071

Review 4.  Candida albicans interactions with epithelial cells and mucosal immunity.

Authors:  Julian R Naglik; David L Moyes; Betty Wächtler; Bernhard Hube
Journal:  Microbes Infect       Date:  2011-07-14       Impact factor: 2.700

5.  Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection.

Authors:  M Feldmesser; Y Kress; P Novikoff; A Casadevall
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 6.  The immune response to fungal infections.

Authors:  Shmuel Shoham; Stuart M Levitz
Journal:  Br J Haematol       Date:  2005-06       Impact factor: 6.998

7.  Estimation of Direct Healthcare Costs of Fungal Diseases in the United States.

Authors:  Kaitlin Benedict; Brendan R Jackson; Tom Chiller; Karlyn D Beer
Journal:  Clin Infect Dis       Date:  2019-05-17       Impact factor: 9.079

Review 8.  Molecular mechanisms of cryptococcal meningitis.

Authors:  Tong-Bao Liu; David S Perlin; Chaoyang Xue
Journal:  Virulence       Date:  2012-03-01       Impact factor: 5.882

Review 9.  What makes Cryptococcus neoformans a pathogen?

Authors:  K L Buchanan; J W Murphy
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

10.  Candida albicans colonization and dissemination from the murine gastrointestinal tract: the influence of morphology and Th17 immunity.

Authors:  Simon Vautier; Rebecca A Drummond; Kong Chen; Graeme I Murray; David Kadosh; Alistair J P Brown; Neil A R Gow; Donna M MacCallum; Jay K Kolls; Gordon D Brown
Journal:  Cell Microbiol       Date:  2014-11-25       Impact factor: 3.715

View more
  7 in total

1.  Comparative miRNA transcriptomics of macaques and mice reveals MYOC is an inhibitor for Cryptococcus neoformans invasion into the brain.

Authors:  Hailong Li; Xiaoxu Han; Wei Du; Yang Meng; Yanjian Li; Tianshu Sun; Qiaojing Liang; Chao Li; Chenhao Suo; Xindi Gao; Yu Qiu; Wen Tian; Minghui An; Hui Zhang; Yajing Fu; Xiaolin Li; Tian Lan; Sheng Yang; Zining Zhang; Wenqing Geng; Chen Ding; Hong Shang
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

Review 2.  Monoclonal Antibodies and Invasive Aspergillosis: Diagnostic and Therapeutic Perspectives.

Authors:  Xihua Lian; Amy Scott-Thomas; John G Lewis; Madhav Bhatia; Sean A MacPherson; Yiming Zeng; Stephen T Chambers
Journal:  Int J Mol Sci       Date:  2022-05-16       Impact factor: 6.208

3.  Quantitative analysis reveals internalisation of Cryptococcus neoformans by brain endothelial cells in vivo.

Authors:  Yanli Chen; Chang Li; Donglei Sun; Ashley B Strickland; Gongguan Liu; Meiqing Shi
Journal:  Cell Microbiol       Date:  2021-04-07       Impact factor: 4.115

4.  Editorial: Neurotropism of Parasites and the Immune Responses.

Authors:  Miriam Postan; Martin E Rottenberg
Journal:  Front Immunol       Date:  2021-10-01       Impact factor: 7.561

5.  Cryptococcal Protease(s) and the Activation of SARS-CoV-2 Spike (S) Protein.

Authors:  Nozethu Mjokane; Maphori Maliehe; Olufemi S Folorunso; Adepemi O Ogundeji; Onele M N Gcilitshana; Jacobus Albertyn; Carolina H Pohl; Olihile M Sebolai
Journal:  Cells       Date:  2022-01-27       Impact factor: 6.600

Review 6.  Invasive Candidiasis: Update and Current Challenges in the Management of This Mycosis in South America.

Authors:  Fernando Oscar Riera; Juan Pablo Caeiro; Sofia Carla Angiolini; Cecilia Vigezzi; Emilse Rodriguez; Paula Alejandra Icely; Claudia Elena Sotomayor
Journal:  Antibiotics (Basel)       Date:  2022-06-30

Review 7.  The Emerging Role of Mast Cells in Response to Fungal Infection.

Authors:  Miao Yu; Xiao-Ting Song; Bo Liu; Ting-Ting Luan; Shuang-Lu Liao; Zuo-Tao Zhao
Journal:  Front Immunol       Date:  2021-06-03       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.